MedPath
FDA Approval

Fentanyl Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 5, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fentanyl(50 ug in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC

964475045

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fentanyl Citrate

Product Details

NDC Product Code
63323-808
Application Number
ANDA212086
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
January 31, 2023
WaterInactive
Code: 059QF0KO0RClass: IACT
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 50 ug in 1 mL
Hydrochloric AcidInactive
Code: QTT17582CBClass: IACT
Sodium HydroxideInactive
Code: 55X04QC32IClass: IACT

Fentanyl Citrate

Product Details

NDC Product Code
63323-810
Application Number
ANDA212086
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
January 31, 2023
Hydrochloric AcidInactive
Code: QTT17582CBClass: IACT
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 100 ug in 2 mL
Sodium HydroxideInactive
Code: 55X04QC32IClass: IACT
WaterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath